Variable | Finnish cohort | Iranian cohort | ||||
---|---|---|---|---|---|---|
PDAC | HC | p valuec | PDAC | HC | p valuec | |
Samples included (n) | 33 | 35 | Â | 50 | 34 | Â |
Agea (years) | 69 ± 8 | 65.0 ± 10.3 | 0.109 | 62.36 ± 11.9 | 40.4 ± 11.6 |  < 0.001 |
Sex (% female) | 57.6 | 60.0 | 0.839 | 40.0 | 52.9 | 0.242 |
BMIa (kg/m2) | 24.8 ± 4.2 | 26.6 ± 4.4 | 0.096 | NA | NA |  |
Biliary stent (%) | 67.7 | 0 | Â | 0 | 0 | Â |
Neoadjuvant treatment (%) | 36.4 | 0 | Â | 0 | 0 | Â |
Smokersb (%) | 40.0 | 28.6 | 0.332 | 32.7 | 11.8 | 0.011 |
Alcohol use (%) | 63.0 | 51.4 | 0.364 | 3.8 | 8.8 | 0.359 |
Previous cancer | 21.2 | 0 | Â | 6.0 | 0 | Â |